| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/22/2023 | Aldeyra Therapeutics, Inc. | ALDX | Exercise | Stock Option (Right to Buy) | 9.6k | $0.55 | $5.3k | | 08/22/2023 |
| 06/30/2023 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (Right to Buy) | 915 | $8.39 | $7.7k | | 06/30/2023 |
| 06/30/2023 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (Right to Buy) | 21.2k | $8.39 | $178.1k | | 06/30/2023 |
| 03/03/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 30.2k | $12.63 | $382.1k | | 03/01/2023 |
| 03/02/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 29k | $12.37 | $358.6k | | 03/01/2023 |
| 03/02/2023 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 18.3k | $0.00 | $0 | | 03/01/2023 |
| 03/01/2023 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 24k | $0.00 | $0 | | 03/01/2023 |
| 03/01/2023 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 96.2k | $0.00 | $0 | | 03/01/2023 |
| 03/01/2023 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 18.3k | $0.00 | $0 | | 03/01/2023 |
| 02/02/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 3.1k | $16.88 | $52.7k | | 02/01/2023 |
| 02/02/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 200 | $17.54 | $3.5k | | 02/01/2023 |
| 02/02/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 1.1k | $14.57 | $15.7k | | 02/01/2023 |
| 02/02/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 600 | $15.55 | $9.3k | | 02/01/2023 |
| 02/01/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 25k | $16.75 | $418.7k | | 02/01/2023 |
| 01/04/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 15k | $14.89 | $223.3k | | 01/03/2023 |
| 01/03/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 23.4k | $15.19 | $355.1k | | 01/03/2023 |
| 01/03/2023 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 1.6k | $16.16 | $26.1k | | 01/03/2023 |
| 06/07/2022 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (Right to Buy) | 53.8k | $3.60 | $193.7k | | 06/07/2022 |
| 06/07/2022 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (Right to Buy) | 2.3k | $3.60 | $8.3k | | 06/07/2022 |
| 04/25/2022 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 20k | $15.18 | $303.7k | | 04/21/2022 |
| 04/22/2022 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 25k | $15.04 | $376.1k | | 04/21/2022 |
| 04/21/2022 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 25k | $15.24 | $380.9k | | 04/21/2022 |
| 03/11/2022 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 56.3k | $15.91 | $896k | | 03/11/2022 |
| 03/02/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted stock units | 18.3k | $0.00 | $0 | | 03/01/2022 |
| 03/01/2022 | Aclaris Therapeutics, Inc. | ACRS | Grant | Employee Stock Option (Right to Buy) | 336.1k | $14.94 | $5M | | 03/01/2022 |
| 03/01/2022 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted stock units | 96k | $0.00 | $0 | | 03/01/2022 |
| 03/01/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted stock units | 96.2k | $0.00 | $0 | | 03/01/2022 |
| 03/01/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted stock units | 18.3k | $0.00 | $0 | | 03/01/2022 |
| 06/08/2021 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (Right to Buy) | 13.5k | $12.97 | $175.5k | | 06/08/2021 |
| 06/08/2021 | Aldeyra Therapeutics, Inc. | ALDX | Grant | Stock Option (Right to Buy) | 583 | $12.97 | $7.6k | | 06/08/2021 |
| 06/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 5.5k | $22.30 | $123k | | 06/01/2021 |
| 06/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 27.7k | $21.51 | $596.7k | | 06/01/2021 |
| 06/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 73k | $0.00 | $0 | | 06/01/2021 |
| 04/22/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 30k | $26.84 | $805.2k | | 04/22/2021 |
| 03/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Payment of Exercise | Common Stock | 8k | $23.25 | $185.6k | | 03/01/2021 |
|